US drug approvals
1 approvals with a product on the US market
- Milophene ANDA072196 · approved 20 Dec 1988
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
- 0Reports naming them
- 3Markets in public records
- 0Regions & countries
- See reportsGrowth in full reports
Free public data on Granata Bio Corp
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on openFDA (opens in a new tab)
Markets where public records show them
Markets we cover where free public records show Granata Bio Corp: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Granata Bio Corp is in.
From our blog
Stories on the topics Granata Bio Corp works in.
Women's Health Supplements: A Growing Focus
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Breast Cancer Screening and Diagnosis: Closing the Gap
Breast cancer is the most common cancer in women worldwide. Finding it early saves lives, but access to…
Read
Fertility Services: Rising Demand and Access Gaps
About 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income.
Read